Goodpasture's Syndrome: Understanding Kidney Autoimmune Disease

Goodpasture's syndrome (anti-GBM disease) is a rare autoimmune disorder characterized by autoantibodies targeting the glomerular basement membrane (GBM) in kidneys and alveolar basement membrane in lungs.

Pathophysiology

  • Autoantibodies: Primarily IgG against α3 chain of type IV collagen (Goodpasture antigen)
  • Targets: Renal glomeruli → rapidly progressive glomerulonephritis; Pulmonary alveoli → alveolar hemorrhage
  • Trigger: Often unknown; possible viral infections, hydrocarbon exposure, smoking, genetic susceptibility (HLA-DR15)

Clinical Presentation

  • Hemoptysis (coughing blood) — pulmonary involvement
  • Hematuria, proteinuria, rapidly rising creatinine — renal involvement
  • Fatigue, anemia, dyspnea
  • May present as renal-limited or pulmonary-limited

Diagnosis

  • Anti-GBM antibody test (serum)
  • Kidney biopsy: linear IgG deposition on GBM (pathognomonic)
  • ANCA may be positive in 20-30% (double-positive)

Treatment

  • Plasmapheresis (removes antibodies)
  • Immunosuppression: Cyclophosphamide + corticosteroids
  • Supportive: dialysis if renal failure, respiratory support if hemorrhage

Prognosis

Early treatment improves renal survival. Delayed diagnosis often leads to ESRD requiring transplant. Relapse is rare after treatment completion.

Kidney Disease - Related Articles